Han-Gi Lee
Fortuna: - $ al 31/07/2026
Fortuna: - $ al 31/07/2026
Han-Gi Lee currently works at Celltrion Healthcare Co., Ltd., as Director from 2011 and Celltrion Healthcare Holdings Co., Ltd., as Auditor from 2020.
Mr. Lee received his graduate degree from Yonsei University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Celltrion, Inc.
Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products -.--% | 01/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Director/Miembro de la Junta | 01/01/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
Celltrion Healthcare Holdings Co., Ltd.
Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Operates as an investment holding company | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion Healthcare Co., Ltd.
Celltrion Healthcare Co., Ltd. BiotechnologyHealth Technology Develops and sells monoclonal antibody biosimilars for the treatment of cancer | Health Technology |
Celltrion Healthcare Holdings Co., Ltd.
Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.